Paeds Vivas · cardiology
Cardiogenic shock and mechanical circulatory support — branching viva
Branching viva from the school-age child who presents in compensated cardiogenic shock after a viral illness, through the cautious-fluid and inotrope resuscitation and the SCAI staging, the escalation to venoarterial extracorporeal membrane oxygenation when shock becomes refractory, the framing of fulminant myocarditis as a bridge to recovery, and the adolescent on a durable ventricular assist device awaiting transplant, whose device choice, goals of support and anticoagulation complication burden are tested.
On this page & tools
Target exams
Stage 1 — The compensated presentation
The examiner presents a six-year-old boy three days after a viral illness. He is cold and mottled with weak pulses, a four-second capillary refill, oliguria and a gallop rhythm. His blood pressure is 95/60 (normal for age) and his lactate is 5.2 mmol/L. The echocardiogram shows globally hypokinetic ventricles. [2]
- Why does the normal blood pressure not exclude shock, and what bedside feature confirms the shock is cardiogenic? Children vasoconstrict to preserve blood pressure until late, so the perfusion state defines shock; the gallop and congestion confirm a cardiogenic cause. [13]
- Describe your initial fluid strategy and contrast it with septic shock. Five-to-ten millilitre-per-kilogram aliquots with reassessment for congestion, deliberately less than the ten-to-twenty of septic shock, because the failing ventricle tolerates volume poorly. [12]
- Assign his SCAI stage and state the trigger for escalation. He is stage C (classic hypoperfusion needing inotropes); the trigger for mechanical support is stage E, refractory collapse. [2]
Stage 2 — The refractory deterioration
Six hours later his blood pressure falls to 60/40, the lactate rises to 8 mmol/L, and he remains oliguric on milrinone, dobutamine and adrenaline. The examiner asks for the definitive intervention. [10]
- What has happened, and what is the definitive next step? He is now in refractory cardiogenic shock (stage D to E); deploy venoarterial extracorporeal membrane oxygenation as the first-line rescue, early. [10] [8]
- What is the goal of support in fulminant myocarditis, and what prognosis should you state to the family? Bridge to recovery; fulminant myocarditis often recovers near-normal ventricular function once supported through the storm. [15]
- What complications must you counsel the family about? Bleeding and thromboembolic stroke from mandatory anticoagulation, infection, haemolysis, limb ischaemia and multiorgan failure from delayed deployment. [7] [8]
Stage 3 — The adolescent on durable support
The examiner moves to the outpatient setting. A fourteen-year-old boy with dilated cardiomyopathy is being evaluated for a durable ventricular assist device after a decompensating admission. [13]
- Which durable device suits him, and which device is used for smaller children? A continuous-flow device such as the HeartMate 3 for an adolescent; the Berlin Heart EXCOR paracorporeal pulsatile pump for small children and infants, as trialled by Fraser and colleagues. [3] [5]
- Define the four goals of mechanical circulatory support and state which applies here. Bridge to recovery, bridge to transplant, bridge to candidacy, destination therapy; this boy is a bridge to transplant. [6] [4]
- How would you frame the disposition and follow-up? A paediatric cardiac intensive care unit with mechanical support and transplant capability; the device allows rehabilitation and home discharge during the wait, making adherence and transition to adult care central. [3] [13]
References
- [1]Amdani S; Rossano JW; Wilmot I; et al Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation, 2024.PMID 38808502
- [2]Baran DA; Grines CL; Bailey S; et al SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society for Cardiovascular Angiography and Interventions (SCAI), and the Society of Thoracic Surgeons (STS). Catheter Cardiovasc Interv, 2019.PMID 31104355
- [3]Fraser CD Jr; Jaquiss RD; Rosenthal DN; et al Prospective trial of a pediatric ventricular assist device. N Engl J Med, 2012.PMID 22873533
- [4]Fraser CD Jr; Jaquiss RD The Berlin Heart EXCOR Pediatric ventricular assist device: history, North American experience, and future directions. Ann N Y Acad Sci, 2013.PMID 23750961
- [5]Almond CS; Morales DL; Blackstone MH; et al Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale. Am Heart J, 2011.PMID 21884857
- [6]Rihal CS; Naidu SS; Givertz MM; et al 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care. J Card Fail, 2015.PMID 26036425
- [7]Assmann A; Boekstegers P; Brcic I; et al Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice guideline. ESC Heart Fail, 2022.PMID 34811959
- [8]Bembea MM; Agus M; Akcan-Arikan A; et al Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs. Pediatr Crit Care Med, 2023.PMID 36995097
- [9]Bhaskar P; Dhar R; Stephenson AL; et al Use of ECMO for Cardiogenic Shock in Pediatric Population. J Clin Med, 2021.PMID 33917910
- [10]Sachdev A; Chauhan S; Gupta D; et al Refractory pediatric cardiogenic shock: A case for mechanical support. Indian J Crit Care Med, 2016.PMID 27994387
- [11]Schranz D Pharmacological Heart Failure Therapy in Children: Focus on Inotropic Support. Handb Exp Pharmacol, 2020.PMID 31707469
- [12]Burkhardt BEA; Rucker G; Stiller B Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric cardiac surgery patients. Cochrane Database Syst Rev, 2024.PMID 39588800
- [13]Rossano JW; Cherng An V; Lin KY; et al Heart failure in children: etiology and treatment. J Pediatr, 2014.PMID 24928699
- [14]Esangbedo ID; Biagas KV; Ma X; et al Pediatric Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review. Pediatr Crit Care Med, 2020.PMID 32345933
- [15]Feng T; Zhao Y; Li L; et al Clinical outcomes of VA-ECMO in children with fulminant myocarditis: a single-centre case series. BMC Pediatr, 2026.PMID 42056983
- [16]Levin A Levosimendan. J Pediatr Intensive Care, 2013.PMID 31214430